Alberta · CCAA
06. Fifth Report of the Monitor
Court officer report · 6 July 2026
AI summary
A plain-English summary drawn only from this filing: what it is, why it matters, and the parties, amounts and dates it turns on.
What we verified from this filing10 verified
- cash on handnote: Made up of $65,737 in the Monitor's trust account, $72,932 in the RBC Accounts (to which the Monitor does not presently have access) and $2,703 held in trust with the CRO. Effective cash after cheques issued and outstanding is $120,661. The report's own sub-items put the $65,737 and $72,932 figures against different holders than Schedule C's labels do (the Schedule C labels appear transposed). · as at: 2026-06-19 · amount: 141372 · currency: CAD
- disbursementsnote: Actual total disbursements per Schedule C, against a forecast of $279,224. · since: April 25, 2026 (actual total through June 19, 2026) · amount: 233677 · currency: CAD
- operational summaryThe Applicants have not operated since Health Canada suspended Sirona Pharma's licence in September 2025. The licence was regained on May 6, 2026. Since the Monitor's expanded powers took effect on May 20, 2026, the Monitor has run the business at minimal levels to maintain the facility and licences while a SISP was run. Management has effectively ceased day-to-day involvement.
- process resultsndas: 9 · note: The Monitor identified over 113 potential bidders; 9 distinct parties executed an NDA; two physical inspections of the Facility were held; all Initial Offers were found non-viable and non-competitive. · solicited: 113
- professional feesnote: Professional Fees outstanding and accrued. The existing Administration Charge of $500,000 is stated to be insufficient, and the Monitor seeks a Second Administration Charge of $250,000. Future fees to finalize the proceedings are estimated at roughly $200,000. The report does not say whether the figures exclude tax. · party: Monitor ($153,779), Monitor's counsel ($103,818) and Applicants' counsel ($307,573) · amount: 545170 · period: outstanding and accrued up to or around June 19, 2026 · currency: CAD
- purchaserConex Services Inc.
- receipts cumulativenote: Schedule C shows no receipts, forecast or actual, for April 25 to June 19, 2026 (dash). The only cash inflow in that period was $100,000 of DIP proceeds under the Second Interim Financing Agreement, which is not counted as a receipt. · since: April 25, 2026 (forecast-to-actual period ended June 19, 2026) · amount: 0 · currency: CAD
- report date6 July 2026
- report noFifth Report
- sale outcometext: The Monitor selected Conex Services Inc.'s late bid as the Successful Bid and seeks approval of the Subscription Agreement by way of an Approval and Reverse Vesting Order. · scope: whole_business · status: pending_approval